Synthesis and Characterization of mpeg-PCL Copolymers as a Polymersomes for Delivery of Enalapril as a Model Hydrophilic Drug Drug delivery of enalapril by polymersomes
Iranian Journal of Pharmaceutical Sciences,
Vol. 14 No. 2 (2018),
1 April 2018
,
Page 25-38
https://doi.org/10.22037/ijps.v14.40658
Abstract
Enalapril maleate (EPM) was used for hypertension and congestive heart failure. In this way, an innovative delivery system with mPEG–PCL was synthesized and the release profile of the EPM from the drug-loaded polymersomes was evaluated. Di-block methoxy-poly (ethylene glycol) - poly (caprolactone) (mPEG-PCL) copolymers were synthesized and used to prepare polymersomes for the controlled release of EPM as hydrophilic model drug. mPEG-PCL copolymer was characterized in vitro by HNMR, FTIR, DSC, and GPC techniques. The resulting polymersomes were characterized further by various techniques such as dynamic light scattering (DLS) and transmission electron microscopy (TEM). The results of TEM show the polymersomes formed had spherical structure and the size of polymersomes is 80 nm. The loading and encapsulation efficiency of EPM were determinate by HPLC at 215 nm with loading and encapsulation efficiency 19.8% ± 2.12% and 85.6% ± 1.26%, respectively. In vitro release of EPM from polymersomes was clearly sustained in all the time tested for this purpose. The sustained release of drug was hypothetically due to the entrapment of EPM in core of polymersomes. The results indicate the successful formulation of EPM loaded m-PEG/PCL polymersomes. Overall, the results demonstrated that m-PEG-PCL polymersomes can be considered as a promising carrier for hydrophilic drugs such as EPM.
- m-PEG-PCL
- Polymersomes
- EPM
- Hydrophilic drugs
- Drug delivery
How to Cite
References
[2] Lomas H, Canton I, MacNeil S, et al. Biomimetic pH sensitive polymersomes for efficient DNA encapsulation and delivery. Adv Mater (2007) 19:4238–43.
[3] Pang burn TO, Petersen MA, Waybrant B, et al. Peptide and aptamer functionalized nanovectors for targeted delivery of therapeutics. J Biomech Eng Trans ASME (2009) 131:1–20.
[4] Christian DA, Cai S, Bowen DM, et al. Polymersome carriers: from self-assembly to siRNA and protein therapeutics. Eur J Pharm Biopharm (2009) 71: 463–74.
[5] Kim KT, Meeuwissen SA, Nolte RJM, Hest JCM. Smart nanocontainers and nanoreactors. Nanoscale (2010) 2:844–58.
[6] Lomas H, Du JZ, Canton I, et al. Efficient encapsulation of plasmid DNA in pH-sensitive PMPC-PDPA polymersomes: study of the effect of PDPA block length on copolymer-DNA binding affinity. Macromol Biosci (2010) 10:513–30.
[7] Liu G, Ma S, Li S, et al. The highly efficient delivery of exogenous proteins into cells mediated by biodegradable chimaeric polymersomes. Biomaterials (2010) 31:7575–85.
[8] Ahmed F, Pakunlu R, Brannan A, et al. Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug. J Control Release (2006) 116: 150–8.
[9] Li SL, Byrne B, Welsh J, Palmer AF. Self-assembled poly(butadiene)- b-poly (ethylene oxide) polymersomes as paclitaxel carriers. Biotechnol Prog (2007) 23: 278–85.
[10] Chen W, Meng FH, Cheng R, Zhong ZY. PH-sensitive degradable polymersomes for triggered release of anticancer drugs: a comparative study with micelles. J Control Release (2010) 142: 40–6..
[11] Photos PJ, Bacakova L, Discher B, et al. Polymer vesicles in vivo: correlations with PEG molecular weight. J Control Release (2003) 90: 323–34.
[12] Onaca O, Enea R, Hughes DW, Meier W. Stimuli-responsive polymersomes as nanocarriers for drug and gene delivery. Macromol Biosci (2009?) 9: 129–39.
[13] Engbers G.H.M, Feijen J. Biodegradable polymersomes as a basis for artificial cells: encapsulation, release and targeting.J. Control. Release (2005) 101: 187–198.
[14] Meng F, Zhong Z, Feijen J. Stimuli-responsive polymersomes for programmed drug delivery. Biomacromolecules (2009) 10:197–209.
[15] Lee H.J, Yang S.R, An E.J, Kim J.D. Biodegradable polymersomes from poly(2- hydroxyethyl aspartamide) grafted with lactic acid oligomers in aqueous solution, Macromolecules (2006) 39: 4938–4940.
[16] Ahmed F, Discher D.E. Self-porating polymersomes of PEG–PLA and PEG–PCL: hydrolysis-triggered controlled release vesicles J. Control. Release (2004) 96: 37–53.
[17] Wang X, Yang L, Chen ZG, Shin DM. Application of nanotechnology in cancer therapy and imaging. CA Cancer J Clin. (2008) 58:97–110.
[18] Wei X, Gong C, Gou M, et al. Biodegradable poly(epsilon-caprolactone)-poly (ethylene glycol) copolymers as drug delivery system. Int J Pharm (2009) 381:1–18.
[19] Yodthong B. Surfactant-Free Nanospheres of m/PEG-PCL for controlled release of ibuprofen. Journal of Applied Sciences. (2009) 9(12), 2278-79.
[20] Weihui X, Weipu Z, Zhiquan S. Synthesis, isothermal crystallization and micellization of mPEG-PCL diblock copolymers catalyzed by yttrium complex. Polymer. (2007) 48: 6791-6798.
[21] Kumari A, Yadav S.K, Yadav S.C. Biodegradable polymeric nanoparticles based drug delivery systems, Colloids and Surfaces B: Biointerfaces (2010) 75: 1-18.
- Abstract Viewed: 351 times
- IJPS_Volume 14_Issue 2_Pages 25-38 Downloaded: 499 times